Thyroid Flashcards
Primary Hypothyroidism
- Low T4
- High TSH
Secondary Hypothyroidism
- Low T4
- Low TSH
Management of hypothyroidism
- Replacement with thyroid hormone and is lifelong
- Therapeutic goal is -.5-2.5
Over-replacement
- Leads to low TSH
- S/S: affects bone density, cardiac complications
- Brand differences
Levothyroxine tips
- Take on empty stomach
- Before increasing drug, check for angina, diarrhea, or malabsorption
- Long half-life
Drug Interactions: Levothyroxine
- Avoid administering with: Iron, aluminum hydroxide, antacids, sucralfate, cimetidine, calcium supplements or soy milk, with bile acid sequestrants
- Anti-seizure meds may increase hepatic metabolism
- May effect warfarin dosing
Levothyroxine follow-up
- Patients usually notice improvement in 2wk: Less facial puffiness, increased urination, improved energy
- Recheck TSH after 6wk and adjust dosage
- ** Recheck every 6wk until dosage regulated, then check annually
Subclinical management of hypothyroidism
TSH concentration >10mU/L or antithyroid peroxidase antibody with a normal T4: treat with synthetic T4 to prevent progression to overt hypothyroidism
- treatment may be indicated in patients with TSH 5-10mU/L (T4 normal) if these are present: Goiter, nonspecific symptoms, cardiac disease or diabetes
Graves Disease
- antithyroid meds
- Ablation with radioactive iodine
- Surgery: thyroidectomy
- Symptom management
Antithyroid medications
- Methimazole (Tapazole)
- Propylthiouracil (PTU)
- Goal: Inhibit thyroid synthesis until thyroid stores are depleted and euthyroid state achieved (3-8wk)
- remission rates vary from 10-90%
- Reevaluate q3-6mo and check symptoms
- Treat reoccurence with anti-thyroid drugs
- – PTU drug of choice for pregnancy
Graves: Propanolol
- Controls symptoms
- Initially 20mg BID
- Increase to 20-40mg BID-QID: Until improvement in tachycardia, tremor and diaphoresis and anxiety
- Continue until hyperthyroidism is resolved
- Does NOT impact thyroid hormone levels
Antithyroid Drugs: TOC for
- Young adults
- Those with mild thyrotoxicosis, small goiters
- Those with fears of radioactive iodine
- Patients preparing for surgery or radioactive iodine Tx
Graves: Agranulocytosis
- Uncommon but severe complication of antithyroid meds
- Presents in first 3mo of therapy
- S/S: Fever, sore throat, rash, arthralgia, myalgia
- Stop drug immediately and proceed to ED
- Practice implications: Baseline CBC-diff, and then at follow-up
Monitoring antithyroid meds
- Baseline CBC-diff, LFT’s with bilirubin
- Monitor TSH q4-6wk
- Goal: normalize TSH
- If TSH remains low after 6mo of therapy, will likely recur once drugs stopped
- Refer for definitive treatment
Radioactive Iodine
- Goal: Reduce the volume of functioning thyroid tissue
- used most frequently in older patients
- TOC: >20yo and those for whom Tx with antithyroid drugs has failed
- Not preferred for children, adolescents or women in reproductive years
- Contraindicated in pregnancy (U-Preg before, defer pregnancy 3-6mo after)
- Benefits: Definitive, easy, can be repeated